These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2413488)

  • 1. Behaviorally equivalent stressors differentially modify the monoamine altering property of d-amphetamine.
    Klauenberg BJ; Kleven MS; Sparber SB
    Pharmacol Biochem Behav; 1985 Sep; 23(3):417-23. PubMed ID: 2413488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral toxicity of amphetamine is differentially affected by hot and cold water immersion stress.
    Klauenberg BJ; Sparber SB
    Neurobehav Toxicol Teratol; 1983; 5(1):83-90. PubMed ID: 6856013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizure activity and hyperthermia potentiate the increases in dopamine and serotonin extracellular levels in the amygdala during exposure to d-amphetamine.
    Tor-Agbidye J; Yamamoto B; Bowyer JF
    Toxicol Sci; 2001 Mar; 60(1):103-11. PubMed ID: 11222877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
    Robinson TE; Camp DM
    Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamine.
    Chuang LW; Karoum F; Wyatt RJ
    Eur J Pharmacol; 1982 Jul; 81(3):385-92. PubMed ID: 7117382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered central monoamine response to D-amphetamine in rats chronically exposed to inorganic lead.
    Lasley SM; Greenland RD; Minnema DJ; Michaelson IA
    Neurochem Res; 1985 Jul; 10(7):933-44. PubMed ID: 2413381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
    Sabol KE; Seiden LS
    Brain Res; 1998 Sep; 806(1):69-78. PubMed ID: 9739110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone on brain biogenic amine levels.
    Stern WC; Miller M; Jalowiec JE; Forbes WB; Morgane PJ
    Pharmacol Biochem Behav; 1975; 3(6):1115-8. PubMed ID: 1223899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
    Jones GH; Hernandez TD; Kendall DA; Marsden CA; Robbins TW
    Pharmacol Biochem Behav; 1992 Sep; 43(1):17-35. PubMed ID: 1384071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
    Robinson TE; Becker JB
    Brain Res; 1986 Jun; 396(2):157-98. PubMed ID: 3527341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical changes in response to acute stressors: influence of previous chronic exposure to immobilization.
    Pol O; Campmany L; Gil M; Armario A
    Pharmacol Biochem Behav; 1992 Jul; 42(3):407-12. PubMed ID: 1384070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?
    Kuczenski R; Leith NJ
    Pharmacol Biochem Behav; 1981 Sep; 15(3):405-13. PubMed ID: 7291244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of D-amphetamine on responding for candy and fruit drink using a fixed ratio and a progressive ratio schedule of reinforcer delivery.
    Foltin RW; Evans SM
    Pharmacol Biochem Behav; 2001; 69(1-2):125-31. PubMed ID: 11420077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study.
    Bonhomme N; Cador M; Stinus L; Le Moal M; Spampinato U
    Brain Res; 1995 Mar; 675(1-2):215-23. PubMed ID: 7796132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary tryptophan supplements attenuate amphetamine self-administration in the rat.
    Smith FL; Yu DS; Smith DG; Leccese AP; Lyness WH
    Pharmacol Biochem Behav; 1986 Oct; 25(4):849-55. PubMed ID: 2431419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.